Anavex Life Sciences Corp (AVXL)

[Amatuer17]

Good detailed analysis

I have come to the same conclusion and maintained the same view that another P3 will be required but my conclusion was based on much simpler approach -

- the results were not conclusive
- M was presenting data in selective way to make it look good
- the trial had 2 doses and number of patients around 170 for each dose is too small and non-conclusive for FDA to even considering approval of either dose.

AVXL will need another large P3 trial - 1000 patients where they have to use a single dose that they want to recommend for approval and get concrete results to that the dose and drug works.